Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds

Biomaterials

Volumn 32, Issue 19, 2011, Pages 4369-4375

  Xie, Changqing ^a   Hu, Jiang ^b   Ma, Haiyun ^b   Zhang, Jifeng ^a   Chang, Lung Ji ^c   Chen, Y Eugene ^a   Ma, Peter X ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Induced pluripotent stem cells; Scaffolds; Smooth muscle cells; Vascular tissue engineering

Indexed keywords

CELL SOURCES; DIFFERENTIATED CELLS; IN-VITRO; MARKER GENES; MYOCARDIN; NANOFIBROUS SCAFFOLDS; OVER-EXPRESSION; P53 GENE; PLURIPOTENT; PLURIPOTENT STEM CELLS; POLY-L-LACTIDE; REGENERATIVE MEDICINE; SMOOTH MUSCLE CELLS; THREE-DIMENSIONAL (3D); THREE-DIMENSIONAL GROWTH; VASCULAR TISSUE ENGINEERING;

BLOOD VESSELS; CYTOLOGY; DIMETHYL SULFOXIDE; GENE EXPRESSION; MUSCLE; NANOFIBERS; ORGANIC SOLVENTS; STEM CELLS; THREE DIMENSIONAL;

SCAFFOLDS (BIOLOGY);

DIMETHYL SULFOXIDE; MOLECULAR SCAFFOLD; MYOCARDIN; POLYLACTIDE; PROTEIN P53; RETINOID; SMOOTHELIN; TRANSGELIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DATA ANALYSIS; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MEDICAL RECORD; MOUSE; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; VASCULAR TISSUE;

ACTINS; ANIMALS; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; INDUCED PLURIPOTENT STEM CELLS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

IPS;

EID: 79955160302     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.049     Document Type: Article

References (25)

1. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84(3):767-801.
2. Shinoka T., Shum-Tim D., Ma P.X., Tanel R.E., Isogai N., Langer R., et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998, 115(3):536-545.
3. Niklason L.E., Abbott W., Gao J., Klagges B., Hirschi K.K., Ulubayram K., et al. Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg 2001, 33(3):628-638.
4. Hu J., Sun X., Ma H., Xie C., Chen Y.E., Ma P.X. Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials 2010, 31(31):7971-7977.
5. Xu Z.C., Zhang W.J., Li H., Cui L., Cen L., Zhou G.D., et al. Engineering of an elastic large muscular vessel wall with pulsatile stimulation in bioreactor. Biomaterials 2008, 29(10):1464-1472.
6. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282(5391):1145-1147.
7. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
8. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
9. Xie C.Q., Huang H., Wei S., Song L.S., Zhang J., Ritchie R.P., et al. A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev 2009, 18(5):741-748.
10. Lee T.H., Song S.H., Kim K.L., Yi J.Y., Shin G.H., Kim J.Y., et al. Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ Res 2010, 106(1):120-128.
11. Chang L.J., Gay E.E. The molecular genetics of lentiviral vectors-current and future perspectives. Curr Gene Ther 2001, 1(3):237-251.
12. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296(5567):550-553.
13. Chang L.J., Liu X., He J. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Ther 2005, 12(14):1133-1144.
14. Xiong C., Tang D.Q., Xie C.Q., Zhang L., Xu K.F., Thompson W.E., et al. Genetic engineering of human embryonic stem cells with lentiviral vectors. Stem Cells Dev 2005, 14(4):367-377.
15. Wiznerowicz M., Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003, 77(16):8957-8961.
16. Takahashi K., Okita K., Nakagawa M., Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007, 2(12):3081-3089.
17. Blelloch R., Venere M., Yen J., Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 2007, 1(3):245-247.
18. Carey B.W., Markoulaki S., Hanna J., Saha K., Gao Q., Mitalipova M., et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 2009, 106(1):157-162.
19. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B., Raya A., et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460(7259):1140-1144.
20. Hotta A., Cheung A.Y., Farra N., Garcha K., Chang W.Y., Pasceri P., et al. EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat Protoc 2009, 4(12):1828-1844.
21. Raya A., Rodriguez-Piza I., Guenechea G., Vassena R., Navarro S., Barrero M.J., et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009, 460(7251):53-59.
22. Sun G., Gerecht S. Vascular regeneration: engineering the stem cell microenvironment. Regen Med 2009, 4(3):435-447.
23. Kusuma S., Gerecht S. Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders. Expert Rev Cardiovasc Ther 2010, 8(10):1433-1445.
24. Sinha S., Wamhoff B.R., Hoofnagle M.H., Thomas J., Neppl R.L., Deering T., et al. Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells. Stem Cells 2006, 24(7):1678-1688.
25. Wei G., Jin Q., Giannobile W.V., Ma P.X. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release 2006, 112(1):103-110.